Posts

Asepsis announces the USPTO Notice of Allowance for Patent Application No. 14/877,349 encompassing the prefilled and ready to fill, Diluent-2-Dose™ syringe. Read More… U.S. Patented Application 1

Asepsis Medical Announces the Notice of Patent Grant US 9775950 for the Vi-Syringe™ – Vision Impaired Syringe.

Asepsis Medical Announces Notice of Patent Grant 2015209535 in Australia for the Momenta-Dose™ – Force Actuated Injection.

Asepsis Medical announces the Notice of Allowance in Mexico for Patent No. 14/09038 encompassing the Dose-2-Weight Syringe® and Safe-T-Syringe® as well as related Calibrated Drug Delivery™ injection k

Asepsis Medical receives Notice of Allowance in Japan for Patent 2014-554822 encompassing the Oral and Parenteral Dose-2-Weight Syringe® and related Calibrated Drug Deliv

Asepsis Medical Technologies announces the issue of United States Patent 9750883 for its Oral-Dose-2-Weight Syringe® and Parenteral-Dose-2-Weight Syringe®. The Asepsis’&n

Asepsis Medical Technologies announces the Notice of Allowance of Australian Patent Application 2013222819 for its Dose-2-Weight Syringe® and Safe-T-Dose® combinatorial drug injection kit. The Asepsis

Asepsis Medical Technologies announces the USPTO issuance of Patent Number U.S. Patent 9,433,726 for its Safe-T-Fuse™ drug infusion system. The Safe-T-Fuse™ is an industry unique infusion container th